Tag: HeartMate 3
FDA Breakthrough Device Designation for fully implantable left ventricular assist system
The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Abbott for its in-development fully implantable left ventricular assist system (FILVAS)....
US FDA approve HeartMate 3 heart pump for advanced heart failure...
The HeartMate 3 left ventricular assist device has received US FDA approval as a destination therapy for people living with advanced heart failure. With...
Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval
The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...
AHA 2016: MOMENTUM 3 shows HeartMate 3 LVAD improves clinical outcomes...
The results of the MOMENTUM 3 US IDE clinical study, which were presented at a late-breaking clinical trial at the 2016 American Heart Association...
